ADJUSTED EARNINGS PER SHARE EXCLUDING SPECIAL ITEM | Income Before
Income Taxes | Income Tax Expense | Net Income | Earnings Per
Diluted Share* | |||||||||
Three Months Ended March 31, 2023, as reported | $ | 24.0 | $ | (5.4 | ) | $ | 18.6 | $ | 0.38 | ||||
Special item: | |||||||||||||
None reported | — | — | — | — | |||||||||
Three Months Ended March 31, 2023, as adjusted | $ | 24.0 | $ | (5.4 | ) | $ | 18.6 | $ | 0.38 | ||||
* Impact per diluted share calculated using weighted average common shares outstanding of 49.2 million for the three months ended March 31, 2023. |
ADJUSTED LOSS PER SHARE EXCLUDING SPECIAL ITEMS | Loss Before
Income Taxes | Income Tax Benefit | Net Loss | Loss Per
Diluted Share* | ||||||||||||
Three Months Ended March 31, 2022, as reported | $ | (8.3 | ) | $ | 0.8 | $ | (7.5 | ) | $ | (0.16 | ) | |||||
Special items: | ||||||||||||||||
COVID-19 costs | 2.0 | (0.4 | ) | 1.6 | 0.03 | |||||||||||
Acquisition-related contingent liability release | (4.7 | ) | 1.1 | (3.6 | ) | (0.07 | ) | |||||||||
Three Months Ended March 31, 2022, as adjusted | $ | (11.0 | ) | $ | 1.5 | $ | (9.5 | ) | $ | (0.20 | ) | |||||
* Impact per diluted share calculated using weighted average common shares outstanding of 48.6 million for the three months ended March 31, 2022. |